APA (7th ed.) Citation

Ozdemir Isik, O., Karadag, D. T., Tekeoglu, S., Yazici, A., Cefle, K., & Cefle, A. (2024). Long‐term efficacy of canakinumab in hyperimmunoglobulin D syndrome. International Journal of Rheumatic Diseases, 27(1), 1. https://doi.org/10.1111/1756-185X.14857

Chicago Style (17th ed.) Citation

Ozdemir Isik, Ozlem, Duygu Temiz Karadag, Senem Tekeoglu, Ayten Yazici, Kıvanc Cefle, and Ayse Cefle. "Long‐term Efficacy of Canakinumab in Hyperimmunoglobulin D Syndrome." International Journal of Rheumatic Diseases 27, no. 1 (2024): 1. https://doi.org/10.1111/1756-185X.14857.

MLA (9th ed.) Citation

Ozdemir Isik, Ozlem, et al. "Long‐term Efficacy of Canakinumab in Hyperimmunoglobulin D Syndrome." International Journal of Rheumatic Diseases, vol. 27, no. 1, 2024, p. 1, https://doi.org/10.1111/1756-185X.14857.